Fank, H.* , Weekers, L.* , Lovinfosse, P.* , Pottel, H., Seidel, L., Jadoul, A., Bouquegneau, A., BONVOISIN, C., Bovy, C., GROSCH, S., Erpicum, P., Hustinx, R., & Jouret, F. (25 August 2023). The uptake of [18F]-fluorodeoxyglucose by the renal allograft correlates with the acute Banff scores of cortex inflammation but not with the 1-year graft outcomes. Frontiers in Transplantation, 2. doi:10.3389/frtra.2023.1236751 * These authors have contributed equally to this work. |
ERPICUM, P., BONVOISIN, C., GROSCH, S., BOVY, C., Pinto Coelho, T., DETRY, O., JOURET, F., WEEKERS, L., & BOUQUEGNEAU, A. (May 2022). Diagnostic et prise en charge thérapeutique du rejet en transplantation rénale. Revue Médicale de Liège, 77 (5-6), 338-344. |
GROSCH, S., ERPICUM, P., BOUQUEGNEAU, A., JOURET, F., & BOVY, C. (May 2022). Le glomérule dans tous ses états. Revue Médicale de Liège, 77 (5-6), 330-337. |
Erpicum, P., Grosch, S., Bonvoisin, C., Bouquegneau, A., Weekers, L., Radermacher, L., Jouret, F., LEJEUNE, M., Hougrand, O., & Bovy, C. (2022). The Case | An unusual cause of renal vascular thrombi after kidney transplantation. Kidney International, 101 (2), 427-428. doi:10.1016/j.kint.2021.08.008 |
Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386 |
BOUQUEGNEAU, A., ERPICUM, P., GROSCH, S., HABRAN, L., HOUGRAND, O., HUART, J., KRZESINSKI, J.-M., Misset, B., Hayette, M.-P., DELVENNE, P., BOVY, C., Kylies, D., huber, T. B., Puelles, V. G., DELANAYE, P., & Jouret, F. (2021). COVID-19-associated nephropathy includes tubular necrosis and capillarycongestion, with evidence of SARS-CoV-2 in the nephron. Kidney International. doi:10.34067/KID.0006992020 |
HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w |
BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1 |
LOVINFOSSE, P., Weekers, F., Pottel, H., BOUQUEGNEAU, A., BONVOISIN, C., BOVY, C., GROSCH, S., Hustinx, R., & Jouret, F. (2021). [(18)F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05467-0 |
BOVY, C., DELANAYE, P., JOURET, F., & KRZESINSKI, J.-M. (2020). Nouveautés thérapeutiques en Néphrologie : 10 ans d'avancées. Revue Médicale de Liège, 75 (5-6), 336-343. |
ERPICUM, P., GROSCH, S., BOUQUEGNEAU, A., HUART, J., Résimont, G., BOVY, C., HABRAN, L., Delvenne, P., KRZESINSKI, J.-M., BURTEY, S., DELANAYE, P., & Jouret, F. (2020). Atteintes rénales de la COVID-19. Revue Médicale de Liège. Supplément, 75 (supplément 1), 109-S114. |
Résimont, G., DUBOIS, B., BOVY, C., Collart, F., & Krzesinski, J.-M. (2020). La dialyse chronique face à la COVID-19. Revue Médicale de Liège. Supplément, 75 (S1), 41-s47. |
HUART, J., GROSCH, S., BOVY, C., Moutschen, M., & Krzesinski, J.-M. (April 2017). IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report. BMC Nephrology, 18, 139. doi:10.1186/s12882-017-0561-2 |
JADOT, V., Krzesinski, J.-M., VON FRENCKELL, C., BOVY, C., & BOUQUEGNEAU, A. (2017). La néphropathie lupique : les nouvelles perspectives de traitement. Néphrologie et Thérapeutique, 14, 1-12. doi:10.1016/j.nephro.2017.05.002 |
LOVINFOSSE, P.* , Weekers, L.* , BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & JOURET, F. (2016). Fluorodeoxyglucose F Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft Rejection. American Journal of Transplantation. doi:10.1111/ajt.13429 * These authors have contributed equally to this work. |
LOVINFOSSE, P., WEEKERS, L., BOVY, C., BONVOISIN, C., GROSCH, S., KRZESINSKI, J.-M., Hustinx, R., & Jouret, F. (13 September 2015). 18FDG-PET/CT IMAGING IN SUSPECTED ACUTE RENAL ALLOGRAFT REJECTION [Paper presentation]. 17th Congress of the European Society for Organ Transplantation, Brussels, Belgium. |
WEEKERS, L., LOVINFOSSE, P., BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (September 2015). Place de la tomographie à émission de positons au 18FDG couplée à la tomodensitométrie en cas de suspicion de rejet aigu du greffon rénal. Néphrologie et Thérapeutique, 11 (5), 280. |
WEEKERS, L., De Tullio, P., BOVY, C., Poma, L., Marée, R., BONVOISIN, C., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (30 January 2015). Activation of the calcium-sensing receptor before renal ischemia/reperfusion exacerbates kidney injury. American Journal of Translational Research, 7 (1), 128-138. |
Dachy, A., Paquot, F., Debray, F.-G., Bovy, C., Christensen, E. I., Collard, L., & Jouret, F. (2015). In-depth phenotyping of a Donnai-Barrow patient helps clarify proximal tubule dysfunction. Pediatric Nephrology, 30 (6), 1027-31. doi:10.1007/s00467-014-3037-7 |
Warling, O., BOVY, C., COIMBRA MARQUES, C., Noterdaeme, T., DELWAIDE, J., & LOUIS, E. (28 April 2014). Overlap syndrome consisting of PSC-AIH with concomitant presence of a membranous glomerulonephritis and ulcerative colitis. World Journal of Gastroenterology, 20 (16), 4811-4816. doi:10.3748/wjg.v20.i16.4811 |
MILICEVIC, M., GROSCH, S., Krzesinski, J.-M., Moutschen, M., & BOVY, C. (22 January 2014). Un cas particulier d'amyloïdose AA [Paper presentation]. Confrontations anatomocliniques en pathologie rénale et vasculaire, Paris, France. |
Hanssen, O., CASTERMANS, E., BOVY, C., WEEKERS, L., ERPICUM, P., DUBOIS, B., Bours, V., Krzesinski, J.-M., & Jouret, F. (2014). Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. NDT Plus, 7, 282-285. doi:10.1093/ckj/sfu019 |
Jouret, F., De Tullio, P., Poma, L., Marée, R., BOVY, C., & DEFRAIGNE, J. (2014). ACTIVATION OF THE CALCIUM-SENSING RECEPTOR BEFORE RENAL ISCHEMIA/REPERFUSION EXACERBATES KIDNEY INJURY IN MOUSE. Transplant International, 27 suppl 1, 15-20. |
BOVY, C., Crismer, A., & KRZESINSKI, J.-M. (04 May 2013). Traitement de suppléance de l'insuffisance rénale terminale : aspects éthiques et économiques, rôles du médecin généraliste [Paper presentation]. Mini symposium Enseignement Post-Universitaire, Liège, Belgium. |
VAN OVERMEIRE, L., Goffin, E., Krzesinski, J.-M., Saint-Remy, A., Bovy, P., Cornet, G., & BOVY, C. (2013). Peritoneal equilibration test with conventional ‘low pH/high glucose degradation product’ or with biocompatible ‘normal pH/low glucose degradation product’ dialysates: does it matter? Nephrology Dialysis Transplantation, 1946-51. doi:10.1093/ndt/gfs433 |
GROSCH, S., VAN OVERMEIRE, L., Krzesinski, J.-M., & BOVY, C. (2011). La glomérulonéphrite fibrillaire non amyloïde : une cause rare de syndrome néphrotique. Néphrologie et Thérapeutique, 7, 494-498. doi:10.1016/j.nephro.2011.03.001 |
Bovy, C., & Krzesinski, J.-M. (27 April 2010). Le syndrome néphrotique [Paper presentation]. Réunion scientifique, Liège, Belgium. |
Le Goff, C., Kaux, J.-F., Bovy, C., Da Silva, A., & Chapelle, J.-P. (March 2010). Comparaison des taux de BNP et de NT-proBNP chez des patients insuffisants rénaux pour prévenir l'insuffisance cardiaque. Biotribune Magazine, 34, 6-9. doi:10.1007/s11834-010-0004-x |
BOUQUEGNEAU, A., Longton, J., Bovy, C., & Krzesinski, J.-M. (2010). La néphropathie tubulo-interstitielle aiguë: une cause rare d’insuffisance rénale aiguë. Revue Médicale de Liège, 65 (7-8), 459-463. |
Teixeira, J., Le Goff, C., Aldenhoff, M.-C., Bovy, C., Dubois, B., Krzesinski, J.-M., & Chapelle, J.-P. (October 2009). Comparison of myocardial makers for assessing cardiovascular and all cause 3-year mortality in dialysis patients [Poster presentation]. 20th international Congress of Clinical Chemistry and Laboratory Medicine, 35th Brazilian Congress of Clinical Analysis and 8th Brazilian Congress of Clinical Cytology, Fortaleza, Brazil. |
Le Goff, C., Bovy, C., Da Silva, A., Krzesinski, J.-M., & Chapelle, J.-P. (2009). Comparison of BNP and NT-proBNP performances for assessing heart failure in a population of patients with high incidence of with renal insufficiency. Annales de Biologie Clinique, 67 (1). |
Couvreur, T., Szepetiuk, G., Meunier, P., Delbecque, K., Detry, O., Bovy, C., & de Leval, L. (November 2008). L'image du mois. La polykystose rénale autosomique dominante. Revue Médicale de Liège, 63 (11), 637-639. |
Teixeira, J., Aldenhoff, M.-C., Bovy, C., Dubois, B., Krzesinski, J.-M., & Chapelle, J.-P. (May 2008). Low creatine kinase MM (CK-MM) levels are strongly associated with adverse outcome in haemodialysis patients [Poster presentation]. International Symposium of Laboratory Medicine - Brussels 2008, Bruxelles, Belgium. |
Le Goff, C., Bovy, C., Aldenhoff, M.-C., Krzesinski, J.-M., & Chapelle, J.-P. (December 2007). Intérêt pronostique à trois ans de la troponine T cardiaque (cTnT) et du fragment N-terminal du propeptide du peptide natriurétique de type B (NT-proBNP) chez les patients hémodialysés. Immuno-Analyse and Biologie Spécialisée, 22 (6), 377-383. doi:10.1016/j.immbio.2007.09.002 |
Bovy, C., Parotte, M.-C., & Krzesinski, J.-M. (October 2007). Clinico-pathological prognostic factors of IgA vasculitis. Acta Clinica Belgica, 62 (5), 369. |
Parotte, M.-C., Bovy, C., & Krzesinski, J.-M. (29 August 2007). Utilité du mycophénolate mofétil en pathologie rénale en dehors de la transplantation. Revue Médicale Suisse, 3, 1899-1905. |
Bovy, C., Gothot, A., Krzesinski, J.-M., Warling, X., & Beguin, Y. (20 January 2007). Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrology Dialysis Transplantation, 11, 1156-1162. doi:10.1093/ndt/gfl765 |
Le Goff, C., Aldenhoff, M.-C., Bovy, C., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Interest of plasma NT-proBNP determinations for 3-year prognosis in hemodialyzed patients [Poster presentation]. 17th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Amsterdam, Netherlands. |
Parotte, M.-C., Bovy, C., & Krzesinski, J.-M. (2007). La dapsone: une économie de corticoïdes dans le traitement du purpura rhumatoïde? A propos d'un cas observé. Revue Médicale de Liège, 62, 710-712. |
Le Goff, C., Aldenhoff, M.-C., Bovy, C., Krzesinski, J.-M., & Chapelle, J.-P. (26 October 2006). Interest of cTnT and NT-proBNP for 3-year prognosis in hemodialyzed patients [Paper presentation]. CORATA, Brugges, Belgium. |
Bovy, C. (2006). Influence de l'activité érythropoïétique sur le métabolisme et le monitoring martial: Un rôle pour les indices des érythrocytes matures [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315255 |
Krzesinski, J.-M., Delanaye, P., Bovy, C., & Cavalier, E. (2006). Place de la Biologie Clinique dans l'évolution de l'insuffisance rénale et de ses complications [Paper presentation]. Formation continue en Biologie Clinique, Liège, Belgium. |
Bovy, C., Baudoux, E., Salmon, J., & Beguin, Y. (2006). Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Transfusion, 46 (9), 1616-23. doi:10.1111/j.1537-2995.2006.00945.x |
Bovy, C., Delanaye, P., Radermecker, R., Hamoir, E., Maweja, S., & Krzesinski, J.-M. (April 2005). Comment j'explore ... l'hypertension artérielle par excès de minéralocorticoides. Revue Médicale de Liège, 60 (4), 255-63. |
Bataille, Y., Bovy, C., Lancellotti, P., Melchior, V., Delbecque, K., Beguin, Y., & Krzesinski, J.-M. (2005). Primary amyloidosis (AL) as a cause of nephrotic syndrome. Acta Clinica Belgica, 60 (2), 94-7. doi:10.1179/acb.2005.017 |
Bovy, C., Gothot, A., Krzesinski, J.-M., & Beguin, Y. (2005). Mature erythrocyte indices: new markers of iron availability. Haematologica, 90 (4), 549-51. |
Bataille, Y., Bovy, C., Pierard, L., & LANCELLOTTI, P. (October 2004). L'image du mois. Amylose cardiaque. Revue Médicale de Liège, 59 (10), 549. |
Bovy, C., Krzesinski, J.-M., Gothot, A., & Beguin, Y. (2004). Impact of erythropoietic activity on red cell parameters in chronic renal failure patients. Haematologica, 89 (6), 748-9. |
Delanaye, P., Bovy, C., de Leval, L., Fassotte, M.-F., Witvrouw, N., Dechenne, C., Tassin, F., & Krzesinski, J.-M. (2004). Back pain and renal failure. The Lancet, 364 (9449), 1992. doi:10.1016/S0140-6736(04)17484-9 |
Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Hypochromic mature erythrocytes: a specific marker of iron deficiency. Acta Clinica Belgica, 58-3 (4), 325. |
Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Follow-up of iron microalbuminuria in hypertensive patients: a belgian promise survey. Acta Clinica Belgica, 58-3 (4), 328. |
Chapelle, J.-P., Dubois, B., Bovy, C., Aldenhoff, M.-C., Gielen, J., & Rorive, G. (2002). Comparison of plasma cardiac troponins T and I in chronically hemodialyzed patients in relation to cardiac status and age. Clinical Chemistry and Laboratory Medicine, 40 (3), 240-245. doi:10.1515/CCLM.2002.039 |
Pincemail, J., Bovy, C., Chapelle, J.-P., Gielen, J., Defraigne, J., & Rorive, G. (2001). Markers of oxidative stress limited to increased risk of cardiovascular disease in chronic hemodialysis patients. Free Radical Biology and Medicine, 31 (suppl), 345. |
Bovy, C., Dubois, B., Weekers, L., Krzesinski, J.-M., & Rorive, G. (2000). Iron monitoring under vitamin C therapy in hemodialysed patients treated with erythropoietin. Nephrology Dialysis Transplantation, 15 (9), 156. |
Bovy, C., Tsobo, C., Crapanzano, L., Rorive, G., Beguin, Y., Albert, A., & Paulus, J.-M. (1999). Factors determining the percentage of hypochromic red blood cells in hemodialysis patients. Kidney International, 56 (3), 1113-9. doi:10.1046/j.1523-1755.1999.00627.x |
BOVY, C., Saint-Remy, A., Juchmes, A., & Rorive, G. (1998). Lipids, risk factor in hemodialysed patients? Nephrology Dialysis Transplantation, 13, 828. |
BOVY, C., Saint-Remy, A., & Rorive, G. (1997). Intravenous or subcutaneous administration of erythropoietin (rHu-EPO)- what to choose? Nephrology Dialysis Transplantation, 189. |
BOVY, C., DUBOIS, B., popovic, A., Saint-Remy, A., & Rorive, G. (1995). Mode of administration of Erythropoetin (rHu-Epo)- Does it matter? Nephrology Dialysis Transplantation, 10, 1951-1952. |